Our Focus

Our Focus

Massachusetts Prostate Cancer Coalition is a statewide non-profit organization devoted to providing information and education on prostate cancer for newly diagnosed individuals, survivors, men-at-risk, and their families as well as for health care professionals.

MPCC sponsors research on prostate cancer in collaboration with local hospitals and various health care providers and engages people across the Commonwealth in outreach to increase funding for prostate cancer education and research.

MPCC hosts events, funds local research, provides resources for patients and their families, and provides a platform for learning and discussing the issue of prostate cancer.

Support MPCC by becoming a member, making a donation or attending an event. More information can be found here.

 

Five Facts about Prostate Cancer

Five Facts about Prostate Cancer
  1. 1
    Prevalence
    Prostate cancer is the most common (non-skin) cancer in American men.
  2. 2
    Prostate cancer effects 1 in 6 men.
    1 in 6 men will be diagnosed with prostate cancer during their lifetime. This year in Massachusetts another 4,820 new cases will be diagnosed.
  3. 3
    Second leading cause of cancer death in men.
    Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. In Massachusetts, 600 men will die from prostate cancer this year.

  4. 4
    Prostate cancer top risk factors.

    Ethnicity

    African-American men are twice as likely to die of prostate cancer as white men. Asian-Americans and Hispanic/Latinos have lower rates of prostate cancer than non-Hispanic white men.

    Age

    Almost 2 out of 3 prostate cancers are found in men over the age of 65.

  5. 5
    This year 29,720 men will die of prostate cancer.

    Yet, most men diagnosed with prostate cancer will not die from it. In fact, more than 2.5 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today. How do we “live with prostate cancer”?


Statistics from The American Cancer Society 2013

We need your support! Become a Member or Donate to MPCC today.

A recent study titled “Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use Read more read more →

SANTA MONICA, Calif., Oct. 28, 2014 /PRNewswire-USNewswire/ — The Prostate Cancer Foundation (PCF), with funding from the Movember Foundation, proudly announces an innovative program called the Movember Foundation-PCF Scientific Reproducibility Initiative. Due to reports of issues related to the reproducibility of high-impact biomedical research findings, this initiative will assess the reproducibility of research findings with.. read more →